z-logo
open-access-imgOpen Access
Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
Author(s) -
Escanilla Claudio,
Guavita Falla Piedad Marcela,
Cevallos Carolina,
Ávalos Jobet Nicolás,
Bobadilla Bruneau Francisco
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2454
Subject(s) - medicine , doxycycline , lymphoproliferative disorders , dermatology , immunology , lymphoma , antibiotics , microbiology and biotechnology , biology
Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder is a provisional entity according to the last WHO‐EORTC classification. The treatment of choice has not yet been defined. Local therapies have been used with variable response. Doxycycline as a main treatment option is a potential low‐cost and effective alternative for this disorder.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here